Top

Published in:

Open Access 01-05-2019 | Esophageal Cancer | Original Scientific Report

Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment

Authors: Ayako Shimada, Takahiro Tsushima, Yasuhiro Tsubosa, Eisuke Booka, Katsushi Takebayashi, Masahiro Niihara, Mitsuhiro Isaka, Yasuhisa Ohde, Nozomu Machida, Yusuke Onozawa, Hirofumi Yasui, Hiroya Takeuchi, Yuko Kitagawa

Published in: World Journal of Surgery | Issue 5/2019

Abstract

Background

Despite the poor prognosis of recurrent esophageal squamous cell cancer (ESCC), long-term survival could be achieved in a subset of patients who successfully underwent surgical resection for recurrence. In this study, we investigated the outcomes of surgical resection for lymph node (LN) or pulmonary (PUL) recurrence in ESCC patients.

Methods

We retrospectively analyzed the outcomes of ESCC patients who underwent surgical resection between January 2008 and March 2015 for either LN or PUL recurrence after complete response (CR) by chemoradiotherapy or R0 esophagectomy. Every patient fulfilled the original institutional criteria: no recurrence at primary site; recurrence involving in only one organ; expectation of complete resection; and for PUL recurrence, no rapid growth with at least 2 months of observation.

Results

Among the 13 patients analyzed, surgical resection was performed in nine and four patients with LN and PUL recurrence, respectively. R0 resection was achieved in all patients with no fatal surgical complications. Mean duration from the day of the first CR/R0 to the recurrence was 809 (110–2575) days. Median recurrence-free survival following surgical resection for recurrence and overall survival following the first diagnosis of recurrence was 387 and 1297 days, respectively.

Conclusion

Surgical resection for LN or PUL recurrence of ESCC according to our institutional criteria can be performed safely for selected patients.

Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics 2012. CA Cancer J Clin 65(2):87–108CrossRef

Ando N, Kato H, Igaki H et al (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19:68–74CrossRefPubMed

Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12:681–692CrossRefPubMed

Bedenne L, Michel P, Bouche O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168CrossRefPubMed

Nieman DR, Peters JH (2013) Treatment strategies for esophageal cancer. Gastroenterol Clin N Am 42(3):187–197CrossRef

Toh Y (2010) Follow-up and recurrence after a curative esophagectomy for patients with esophageal cancer: the first indicators for recurrence and their prognostic values. Esophagus 7(1):37–43CrossRef

Ishihara R, Yamamoto S, Iishi H et al (2010) Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 76(1):123–129CrossRefPubMed

Su XD, Zhang DK, Zhang X et al (2014) Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma. J Thorac Dis 6(7):949–957PubMedPubMedCentral

Mariette C, Balon JM, Piessen G et al (2003) Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 97:1616–1623CrossRefPubMed

10.

The Japan Esophageal Society (2017) Guidelines for diagnosis and treatment of carcinoma of the esophagus 2017 edition. Kanehara-shuppan

11.

Nakamura T, Ota M, Narumiya K et al (2008) Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol 15(9):2451–2457CrossRefPubMed

12.

Yano M, Takachi Y, Doki Y et al (2006) Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer. Dis Esophagus 19:73–77CrossRefPubMed

13.

Motoyama S, Kitamura M, Saito R et al (2006) Outcome and treatment strategy for mid-and lower-thoracic esophageal cancer recurring locally in the lymph nodes of the neck. World J Surg 30:191–198. https://doi.org/10.1007/s00268-005-0092-z CrossRefPubMed

14.

Kozu Y, Sato H, Tsubosa Y et al (2011) Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: experience from a single institution. J Cardiothorac Surg 6:135CrossRefPubMedPubMedCentral

15.

Ichikawa H, Kosugi S, Nakagawa S et al (2011) Operative treatment for metachronous pulmonary metastasis from esophageal carcinoma. Surgery 149:164–170CrossRefPubMed

16.

Chen F, Sato K, Sakai H et al (2008) Pulmonary resection for metastasis from esophageal carcinoma. Interact Cardiovasc Thorac Surg 7:809–812CrossRefPubMed

17.

Japanese Esophageal Society (2017) Japanese classification of esophageal cancer, 11 edition: part II and III. Esophagus 14:37–65CrossRef

18.

Thomford NR, Woolner LB, Clagett OT (1965) The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg 49:357–363PubMed

19.

Bhansali M, Fujita H, Kakegawa T et al (1997) Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 21:275–281. https://doi.org/10.1007/s002689900228 CrossRefPubMed

20.

Yuan X, Lv J, Dong H et al (2017) Does cervical lymph node recurrence after oesophagectomy or definitive chemoradiotherapy for thoracic oesophageal squamous cell carcinoma benefit from salvage treatment? Interact Cardiovasc Thorac Surg 24:792–795CrossRefPubMed

21.

Nakagawa S, Kanda T, Kosugi S et al (2004) Recurrence patterns of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 198:205–211CrossRef

Title: Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment
Authors: Ayako Shimada
Takahiro Tsushima
Yasuhiro Tsubosa
Eisuke Booka
Katsushi Takebayashi
Masahiro Niihara
Mitsuhiro Isaka
Yasuhisa Ohde
Nozomu Machida
Yusuke Onozawa
Hirofumi Yasui
Hiroya Takeuchi
Yuko Kitagawa
Publication date: 01-05-2019
Publisher: Springer International Publishing
Keywords: Esophageal Cancer
Esophagus Resection
Esophageal Cancer
Esophagus Resection
Published in: World Journal of Surgery / Issue 5/2019
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-018-04904-w

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive Treatment

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2019

Low-fidelity Paediatric Surgical Simulation: Description of Models in Low-Resource Settings

Intrahepatic Glissonian Approach to the Ventral Aspect of the Arantius Ligament in Laparoscopic Left Hemihepatectomy

Global Disparities in Breast Cancer Genetics Testing, Counselling and Management

Correction to: Authors’ Reply: Routine Pathology and Postoperative Follow-Up are not Cost-Effective in Cholecystectomy for Benign Gallbladder Disease

Identifying Information Gaps in a Surgical Capacity Assessment Tool for Developing Countries: A Methodological Triangulation Approach

Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections?